Multiple endocrine neoplasia type 2

Jump to: navigation, search

For patient information, click here.

Multiple endocrine neoplasia type 2 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Multiple endocrine neoplasia type 2 On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 2

CDC on Multiple endocrine neoplasia type 2

Multiple endocrine neoplasia type 2 in the news

Blogs on Multiple endocrine neoplasia type 2</small>

Directions to Hospitals Treating Multiple endocrine neoplasia type 2

Risk calculators and risk factors for Multiple endocrine neoplasia type 2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Synonyms and Keywords: Familial endocrine adenomatosis type 2; Familial endocrine adenomatosis type 2a; Familial endocrine adenomatosis type 2b; Familial chromaffinomatosis type 2; Familial medullary thyroid carcinoma; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasia syndrome type 2; Multiple endocrine neoplasia syndrome type 2a; Multiple endocrine neoplasia syndrome type 2b; MEN type 2; MEN type 2a; MEN type 2b; MEN 2 syndrome; MEN type II; MEN type IIa; MEN type IIb; MEA type 2; MEA type 2a; MEA type 2b; Multiple endocrine neoplasms type 2; Multiple endocrine neoplasms type 2a; Multiple endocrine neoplasms type 2b; Multiple neuroma syndrome type 2; Multiple neuroma syndrome type 2a; Multiple neuroma syndrome type 2b; PTC syndrome; Sipple's syndrome; Pheochromocytoma and amyloid producing medullary thyroid carcinoma; Wagenmann-Froboese syndrome

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria | History & Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

See also

​​​


Linked-in.jpg